These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 37767187)
101. Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3. Zhao C; Li Y; Chen G; Wang F; Shen Z; Zhou R Oncol Rep; 2017 Jul; 38(1):352-358. PubMed ID: 28560431 [TBL] [Abstract][Full Text] [Related]
102. Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma. Wu HG; Zhang WJ; Ding Q; Peng G; Zou ZW; Liu T; Cao RB; Fei SJ; Li PC; Yang KY; Hu JL; Dai XF; Wu G; Li PD Oncol Rep; 2014 Dec; 32(6):2687-95. PubMed ID: 25310770 [TBL] [Abstract][Full Text] [Related]
103. Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma. Bai G; Yang M; Zheng C; Zhang L; Eli M Oncol Lett; 2018 Apr; 15(4):5703-5711. PubMed ID: 29552204 [TBL] [Abstract][Full Text] [Related]
104. Fam72a functions as a cell-cycle-controlled gene during proliferation and antagonizes apoptosis through reprogramming PP2A substrates. Fu Y; Jia X; Yuan J; Yang Y; Zhang T; Yu Q; Zhou J; Wang T Dev Cell; 2023 Mar; 58(5):398-415.e7. PubMed ID: 36868233 [TBL] [Abstract][Full Text] [Related]
105. Golgi scaffold protein PAQR3 as a candidate suppressor of gastric cardia adenocarcinoma via regulating TGF-β/Smad pathway. Wu YL; Hong LL; Ling ZN; Hu XY; Liu Z; Li P; Ling ZQ J Clin Lab Anal; 2022 Sep; 36(9):e24617. PubMed ID: 35870178 [TBL] [Abstract][Full Text] [Related]
106. The value of erlotinib related target molecules in kidney renal cell carcinoma via bioinformatics analysis. Zhang Y; Tang M; Guo Q; Xu H; Yang Z; Li D Gene; 2022 Mar; 816():146173. PubMed ID: 35026294 [TBL] [Abstract][Full Text] [Related]
107. Circular RNA hsa_circ_0043280 inhibits cervical cancer tumor growth and metastasis via miR-203a-3p/PAQR3 axis. Zhang C; Liu P; Huang J; Liao Y; Pan C; Liu J; Du Q; Liu T; Shang C; Ooi S; Chen R; Xia M; Jiang H; Xu M; Zou Q; Zhou Y; Huang H; Pan Y; Yuan L; Wang W; Yao S Cell Death Dis; 2021 Sep; 12(10):888. PubMed ID: 34588429 [TBL] [Abstract][Full Text] [Related]
108. PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability. Jin L; Tong L Immun Inflamm Dis; 2021 Sep; 9(3):827-839. PubMed ID: 33955706 [TBL] [Abstract][Full Text] [Related]
109. PAQR3 Inhibits Non-small Cell Lung Cancer Growth by Regulating the NF-κB/p53/Bax Axis. Guo Q; Ke XX; Fang SX; Gao WL; Song YX; Chen C; Lu HL; Xu G Front Cell Dev Biol; 2020; 8():581919. PubMed ID: 33123538 [TBL] [Abstract][Full Text] [Related]
110. Prognostic and clinicopathologic significance of PAQR3 and VEGF-A expression in pulmonary adenocarcinoma. Shen XC; Zhan SH; Xu ST; Gu GJ Int J Clin Exp Pathol; 2020; 13(7):1676-1681. PubMed ID: 32782688 [TBL] [Abstract][Full Text] [Related]
111. Characterization of the Golgi scaffold protein PAQR3, and its role in tumor suppression and metabolic pathway compartmentalization. Lei L; Ling ZN; Chen XL; Hong LL; Ling ZQ Cancer Manag Res; 2020; 12():353-362. PubMed ID: 32021448 [TBL] [Abstract][Full Text] [Related]
112. MiR-15b facilitates breast cancer progression via repressing tumor suppressor PAQR3. Qi LQ; Sun B; Yang BB; Lu S Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):740-748. PubMed ID: 32016977 [TBL] [Abstract][Full Text] [Related]
113. Cancer statistics, 2020. Siegel RL; Miller KD; Jemal A CA Cancer J Clin; 2020 Jan; 70(1):7-30. PubMed ID: 31912902 [TBL] [Abstract][Full Text] [Related]
114. An EMT-related gene signature for the prognosis of human bladder cancer. Cao R; Yuan L; Ma B; Wang G; Qiu W; Tian Y J Cell Mol Med; 2020 Jan; 24(1):605-617. PubMed ID: 31657881 [TBL] [Abstract][Full Text] [Related]
115. PAQR3 suppresses the growth of non-small cell lung cancer cells via modulation of EGFR-mediated autophagy. Cao Q; You X; Xu L; Wang L; Chen Y Autophagy; 2020 Jul; 16(7):1236-1247. PubMed ID: 31448672 [TBL] [Abstract][Full Text] [Related]
116. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903 [TBL] [Abstract][Full Text] [Related]
117. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC). Hsu PC; Jablons DM; Yang CT; You L Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387256 [TBL] [Abstract][Full Text] [Related]
118. PAQR3 modulates blood cholesterol level by facilitating interaction between LDLR and PCSK9. Huang M; Zhao Z; Cao Q; You X; Wei S; Zhao J; Bai M; Chen Y Metabolism; 2019 May; 94():88-95. PubMed ID: 30831144 [TBL] [Abstract][Full Text] [Related]
119. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT). Cho ES; Kang HE; Kim NH; Yook JI Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699 [TBL] [Abstract][Full Text] [Related]
120. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling. Zhang Z; Shao L; Wang Y; Luo X Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]